Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Anti-CAR Immunity Drives Acquired Therapeutic Resistance to GD2-CAR T Cell Therapy in Diffuse Midline Glioma.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Atlas-based Multi-Parametric Quantitative Brain MRI Analysis of Children with Neurofibromatosis Type 1.
Journal: Clinical neuroradiology
Published: February 17, 2026
Age-related white matter alterations in children with neurofibromatosis type 1: a diffusion MRI tractography study.
Journal: Frontiers in neuroscience
Published: December 10, 2024
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 08, 2024
Pediatric Palliative Care Education in Child Neurology Residency: A National Needs Assessment.
Journal: Pediatric neurology
Published: November 07, 2024
Sequential intravenous and intracerebroventricular GD2-CAR T-cell therapy for H3K27M-mutated diffuse midline gliomas.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2024
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.
Journal: Nature
Published: June 19, 2024
Indications for continuous electroencephalography and frequency of electrographic seizure detection in a pediatric and neonatal cardiovascular intensive care unit.
Journal: Epilepsia
Published: April 14, 2024
An international study presenting a federated learning AI platform for pediatric brain tumors.
Journal: Nature communications
Published: January 04, 2024
Spinal Neurofibromatosis (SNF): A Variant Phenotype of Neurofibromatosis Type 1 (NF1).
Journal: The Journal of pediatrics
Published: May 18, 2023
Last Updated: 09/26/2026